These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 712546)

  • 1. [Studies on the dissolution test of the solid dosage form. I. Correlation of bioavailability and dissolution rate of isonicotinic acid hydrazide tablet (author's transl)].
    Ogata H; Suzuki S; Shibazaki T; Ejima A; Inoue T
    Yakugaku Zasshi; 1978 Jul; 98(7):823-31. PubMed ID: 712546
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissolution systems for chloramphenicol tablet bioavailability.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the extent of pharmaceutical formulation on bioavailability of sulfamethoxazol in human (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Takagishi Y; Doi Y
    Yakugaku Zasshi; 1978 May; 98(5):676-8. PubMed ID: 660443
    [No Abstract]   [Full Text] [Related]  

  • 4. Bio-availability of INH in liquid dosage form.
    Chavan SR; Nikam ST; Pradhan DV; Bhide MB; Gaitonde BB
    Indian J Physiol Pharmacol; 1974; 18(2):120-2. PubMed ID: 4412195
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiazides IV: Comparison of dissolution with bioavailability of chlorothiazide tablets.
    Shah VP; Knight P; Prasad VK; Cabana BE
    J Pharm Sci; 1982 Jul; 71(7):822-4. PubMed ID: 7120073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms.
    Chemburkar PB; Smyth RD; Buehler JD; Shah PB; Joslin RS; Polk A; Reavey-Cantwell NH
    J Pharm Sci; 1976 Apr; 65(4):529-33. PubMed ID: 1271252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New in vitro dissolution test apparatus.
    Nasir SS; Wilken LO; Nasir SM
    J Pharm Sci; 1979 Feb; 68(2):177-81. PubMed ID: 423087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
    Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ
    Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.
    Shete AS; Yadav AV; Murthy MS
    Drug Dev Ind Pharm; 2013 May; 39(5):716-23. PubMed ID: 22639963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DETERMINATION OF ISONICOTINIC ACID HYDRAZIDE IN VARIOUS SUBSTANCES AND TABLETS WITH CU2+ IONS IN THE PRESENCE OF ACETONE].
    ZOMMER S; LIPIEC T
    Acta Pol Pharm; 1963; 20():229-32. PubMed ID: 14054942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigations in Bioavailability of resinates as peroral retard drug dosage forms. Part 1: Pharmaceutical availability of dihydrocodein-resinates (author's transl)].
    Mühlenbruch B; Strauss H; Glaubitz H
    Pharmazie; 1982 Mar; 37(3):200-3. PubMed ID: 7100242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)].
    Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H
    Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of various factors on the in vitro velocity of drug release from repository tablets. Part 4: Isoniazid (Rimicid) respository tablets (author's transl)].
    Tomassini L; Michailova D; Naplatanova D; Slavtschev P
    Pharmazie; 1979 Dec; 34(12):812-4. PubMed ID: 545350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
    Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
    J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
    Sawicki E; Schellens JH; Beijnen JH; Nuijen B
    Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.